Members of the community are invited to the Great Lakes Breast Cancer Symposium—hosted virtually by the Case Comprehensive Cancer Center—Oct. 25–26. This annual symposium highlights ongoing basic, ...
Dr Harold J. Burstein, of the Dana-Farber Cancer Institute in Boston, Massachusetts, highlights key abstracts on early breast cancer from the 2023 American Society of Clinical Oncology (ASCO) annual ...
Alpha Tau treated the first patient in its U.S. multi-center pancreatic cancer clinical trial in September 2025. The trial is expected to enroll up to 30 patients with newly diagnosed pancreatic ...
Processa Pharmaceuticals, Inc., a clinical-stage company specializing in next-generation cancer therapies, announced the acceptance of three abstracts for presentation at the 2025 American Society of ...
Studies presented at the Society of Gynecologic Oncology Annual Meeting offer promising new therapies across subgroups of patients with ovarian cancer, according to Dr Shannon Westin of MD Anderson ...
WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene today announced that eight abstracts were selected for poster presentations at the American Association for Cancer Research (AACR) Annual Meeting 2023, ...
CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced that 18 abstracts, including one oral ...
HENDERSON, Nev.,, December 8, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces the presentation of two abstracts at the North ...
Pancreatic cancer multi-center clinical trial in U.S. is underway; patient recruitment expected to be completed by the end of Q1 2026 "I am delighted that exciting additional pancreatic cancer study ...
JERUSALEM, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ®, ...
Pancreatic cancer multi-center clinical trial in U.S. is underway; patient recruitment expected to be completed by the end of Q1 2026 JERUSALEM, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback